Cross Country Healthcare (CCRN) reported $339.77 million in revenue for the quarter ended June 2024, representing a year-over-year decline of 37.2%. EPS of $0.10 for the same period compares to $0.69 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $334.33 million, representing a surprise of +1.63%. The company delivered an EPS surprise of -28.57%, with the consensus EPS estimate being $0.14.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Cross Country performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Nurse and allied staffing statistical data - FTEsn

  : 8,415 versus the three-analyst average estimate of 8,093.

• Physician staffing statistical data - Days filled in HRS

  : 24,252 versus 18,924 estimated by two analysts on average.

• Physician staffing statistical data - Revenue per day filled

  : $1,992 compared to the $1,894 average estimate based on two analysts.

• Nurse and allied staffing statistical data - Average revenue per FTE per day

  : $377 compared to the $387.50 average estimate based on two analysts.

• Revenue- Physician staffing

  : $48.32 million versus $48.15 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.

• Revenue- Nurse and allied staffing

  : $291.45 million compared to the $284.91 million average estimate based on four analysts. The reported number represents a change of -41.2% year over year.

View all Key Company Metrics for Cross Country here>>>

Shares of Cross Country have returned +32.2% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cross Country Healthcare, Inc. (CCRN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research